Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Corbus Pharmaceuticals Holdings (CRBP) Invested Capital (2016 - 2025)

Corbus Pharmaceuticals Holdings has reported Invested Capital over the past 10 years, most recently at $9.0 million for Q4 2023.

  • For Q4 2023, Invested Capital fell 82.61% year-over-year to $9.0 million; the TTM value through Dec 2023 reached $9.0 million, down 82.61%, while the annual FY2023 figure was $9.0 million, 82.61% down from the prior year.
  • Invested Capital for Q4 2023 was $9.0 million at Corbus Pharmaceuticals Holdings, down from $18.2 million in the prior quarter.
  • Over five years, Invested Capital peaked at $92.3 million in Q1 2021 and troughed at $6.2 million in Q4 2019.
  • A 5-year average of $49.0 million and a median of $47.9 million in 2019 define the central range for Invested Capital.
  • Biggest five-year swings in Invested Capital: surged 648.22% in 2020 and later tumbled 82.61% in 2023.
  • Year by year, Invested Capital stood at $6.2 million in 2019, then surged by 648.22% to $46.1 million in 2020, then soared by 90.65% to $87.8 million in 2021, then plummeted by 41.06% to $51.8 million in 2022, then tumbled by 82.61% to $9.0 million in 2023.
  • Business Quant data shows Invested Capital for CRBP at $9.0 million in Q4 2023, $18.2 million in Q3 2023, and $27.9 million in Q2 2023.